3 ms·
Purposefully priced? Gilead did pay $11 billion to acquire Pharmasset and at one point was facing a $2.5 billion patent infringement ruling (later overturned)
by zaroth 8y ago
Purposefully priced?
Gilead did pay $11 billion to acquire Pharmasset and at one point was facing a $2.5 billion patent infringement ruling (later overturned) for that same drug.
AbbVie’s a new entrant which can treat certain strains at at about a third the cost.
Damn that Late Stage Capitalism developing a miracle cure for Hep C which is painless and effective.
- Pharmakon 8y agoThis is the same AbbVie who’s treatment costs $26,000 right? I think it’s fair to say that’s priced well out of reach for most people, whatever the cost relative to Gilead’s product, which the CEO apologized for. The same AbbVie that sued the NHS? https://outline.com/brsHyA https://outline.com/brsHyA Incidentally Gilead made $5.8 billion in a single quarter so I think we can safely assume they managed to defray the cost of acquiring Pharmasset, don’t you think? Companies making tens of billions a year while poor people suffer and die does seem to be a fairly negative situation, however you care to label it.
- RugnirViking 8y agoI simply refuse to believe that treatments that cost the same as a brand new luxury car are down to labour + materials cost of some pills. There are absurdly massive inefficiencies if as you say they aren't making profits.